Eli Lilly announces new $4.5bn US site for manufacturing and drug development
Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials, Lilly said.